このページは機械翻訳されています。他のページは英語で表示される場合があります。 View in English

呼吸不全後の影響:COVID-19後の肺線維症

  • 0Oklahoma Center for Respiratory and Infectious Diseases, Oklahoma State University, Stillwater, OK 74074, USA.

|

|

まとめ

この要約は機械生成です。

長期のCOVIDは,COVID-19後の肺線維症として知られる,持続的な肺の傷を引き起こす可能性があります. このレビューでは,患者の改善のためのメカニズム,診断,および潜在的な治療法を調査します.

科学分野

  • 肺科
  • 感染症
  • 病理学について

背景

  • SARS-CoV-2 感染症の急性後遺症 (PASC),または長期COVIDは,回復後の多くの個人に影響します.
  • ポストCOVID-19肺線維症 (PC19-PF) は,進行性肺の痕や慢性呼吸器疾患を引き起こす深刻な長期COVID合併症である.
  • PC19- PFの病原性は十分に理解されていないため,効果的な治療の開発を妨げています.

研究 の 目的

  • COVID-19後の肺線維症 (PC19-PF) の包括的なレビューを提供すること.
  • PC19-PFの疫学,臨床的特徴,診断方法,および根本的なメカニズムを解明する.
  • 他の繊維性肺疾患との共通経路を探求し,新たな治療戦略について議論する.

主な方法

  • PC19- PFに関する臨床および実験研究の文献レビュー.
  • 疫学データと臨床症状の分析
  • メカニズム的な洞察と治療方法の統合

主要な成果

  • PC19- PFは慢性呼吸器障害につながる進行性肺の痕として現れます.
  • 共有された線維経路を理解することで,新しい治療目標を提供することができます.
  • 新興戦略はPC19-PFの根本的なメカニズムに取り組むことを目的としています.

結論

  • PC19-PFは,COVID-19の重大な長期的な合併症である.
  • 効果的な治療法の開発には,PC19-PFの病原性に関するさらなる研究が不可欠です.
  • 現在の知識の統合は,肺線維症のメカニズムベースの治療法の開発を導くことができます.

関連する概念動画

COPD: Pathogenesis and Clinical Features 01:20

516

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

Chronic Obstructive Pulmonary Disease-II: Pathophysiology 01:20

3.1K

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

• Inhalation of Irritants: Inhaling irritants, especially cigarette smoke, are primary causes of inflammation in COPD. Other irritants can include...

Chronic Obstructive Pulmonary Disease 01:22

1.4K

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...

Pulmonary Hypertension: Classification and Pathogenesis 01:30

284

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications. 01:25

2.9K

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:

• Chronic Cough: A persistent cough, often productive, is a crucial symptom of COPD.
•...

Other Pulmonary Disorders 01:17

905

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.